Information for "Pembrolizumab (Keytruda)"
Jump to navigation
Jump to search
View the protection log for this page.
Basic information
| Display title | Pembrolizumab (Keytruda) |
| Default sort key | Pembrolizumab (Keytruda) |
| Page length (in bytes) | 46,169 |
| Page ID | 887 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 1 |
| Counted as a content page | Yes |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | PeterYang (talk | contribs) |
| Date of page creation | 15:13, 6 September 2014 |
| Latest editor | Jwarner (talk | contribs) |
| Date of latest edit | 10:54, 18 June 2024 |
| Total number of edits | 227 |
| Total number of distinct authors | 5 |
| Recent number of edits (within past 90 days) | 7 |
| Recent number of distinct authors | 1 |